Your session is about to expire
← Back to Search
Cognitive Behavioral Therapy
Tele-CBT for Crohn's Disease (ADEPT Trial)
N/A
Waitlist Available
Led By Chung Sang Tse
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
ADEPT Trial Summary
This trial will test if telehealth therapy can help adults with IBD manage their disability and improve quality of care.
Who is the study for?
Adults over 18 with Crohn's disease or ulcerative colitis and moderate-to-severe disability can join this trial. They must be willing to do an online survey, speak English, and not have seen a mental health specialist in the last 3 months. Those without internet access or a private space for teletherapy sessions cannot participate.Check my eligibility
What is being tested?
The study is testing if cognitive behavioral therapy (CBT) delivered through telehealth by licensed psychologists helps people with IBD better than usual care does. Participants are randomly chosen to receive either the CBT telehealth intervention or continue their regular treatment.See study design
What are the potential side effects?
Since this trial involves psychological therapy via telemedicine rather than medication, typical drug side effects aren't expected. However, participants may experience emotional discomfort discussing personal issues during therapy.
ADEPT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in the IBD Disability Index
Secondary outcome measures
Cost-benefits of telemedicine-delivered psychosocial care
ADEPT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-CBTExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tele-CBT
2023
N/A
~670
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,421 Total Patients Enrolled
Crohn's and Colitis FoundationOTHER
43 Previous Clinical Trials
27,230 Total Patients Enrolled
Chung Sang TsePrincipal InvestigatorUniversity of Pennsylvania
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Tele-CBT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still openings available for volunteers in this experiment?
"Affirmative. Clinicaltrials.gov has information that this research study is actively seeking participants; it was initially posted on February 15th 2023 and recently updated on April 12th of the same year. The clinical trial aims to recruit 420 individuals from a single site."
Answered by AI
What is the enrollment tally for this experiment?
"Affirmative. Records found on clinicaltrials.gov verify that this medical trial, originally posted on 15th February 2023, is actively seeking out participants. 420 volunteers are expected to be recruited from 1 site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger